Skip to main content

Want a detailed portfolio tracker?

Onconetix (ONCO) P/E (2025 - 2026)

Onconetix (ONCO) P/E from Jun 30, 2025 to Jul 20, 2026. The TTM Onconetix (ONCO) P/E is -0.80. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Onconetix (ONCO)

YearP/EChange
2026-0.80-98.72%
2025-62.39N/A

Comparison Onconetix (ONCO) P/E with competitors

Onconetix (ONCO) P/E is -0.80.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.21%
NBYStablecoin Development Corp0.00-100.54%
ENLVEnlivex Ltd0.07-109.35%
FGENFibroGen Inc0.24-130.01%
CHRSCoherus Biosciences Inc0.85-206.07%
FBIOFortress Biotech Inc0.95-218.64%
ORMPOramed Pharmaceuticals Inc1.50-287.89%
AGENAgenus Inc3.01-476.22%
INVAInnoviva Inc3.15-494.27%
VXRTVaxart Inc3.55-543.74%
CRMDCorMedix Inc3.63-553.58%
CVACCureVac N.V.4.45-655.73%
GLPGGalapagos NV4.86-707.39%
SRPTSarepta Therapeutics Inc4.88-710.29%
ABEOAbeona Therapeutics Inc5.39-773.47%
ABUSArbutus Biopharma Corp5.60-799.48%
ZVRAZevra Therapeutics Inc5.89-835.94%
SPROSpero Therapeutics Inc6.23-878.59%
CGENCompugen Ltd6.31-889.28%
RIGLRigel Pharmaceuticals6.87-959.05%
SLXNSilexion Therapeutics Corp7.30-1012.05%
OMEROmeros Corporation9.26-1257.40%
AUPHAurinia Pharmaceuticals Inc9.58-1298.18%
PLXProtalix BioTherapeutics Inc10.89-1461.44%
ACADAcadia Pharmaceuticals Inc11.73-1566.14%
TBPHTheravance Biopharma Inc12.26-1632.84%
ADMAAdma Biologics Inc12.42-1652.34%
HRMYHarmony Biosciences Holdings Inc13.82-1827.61%
SABSSAB Biotherapeutics Inc14.14-1867.11%
NAGENiagen Bioscience Inc14.82-1952.36%
INCYIncyte Corp15.82-2077.92%
REGNRegeneron Pharmaceuticals Inc15.86-2082.18%
PBYIPuma Biotechnology Inc17.32-2264.57%
CPRXCatalyst Pharmaceuticals Inc17.44-2280.02%
EXELExelixis Inc17.54-2292.36%
TGTXTG Therapeutics Inc18.97-2470.88%
MDXGMimedx Group Inc20.55-2669.19%
XOMAXOMA Royalty Corp22.87-2959.56%
ARGXArgen X SE24.30-3137.48%
CTMXCytomX Therapeutics Inc24.82-3202.88%
XOMAOXOMA Royalty Corp25.34-3268.35%
HALOHalozyme Therapeutics Inc25.62-3303.21%
XOMAPXOMA Royalty Corp25.67-3309.01%
VRTXVertex Pharmaceuticals Inc27.99-3599.61%
RPRXRoyalty Pharma plc - Class A28.69-3686.22%
SLNOSoleno Therapeutics Inc29.02-3727.20%
ASNDAscendis Pharma A/S30.09-3860.98%
LGNDLigand Pharmaceuticals Inc - Class B37.91-4839.37%
APLSApellis Pharmaceuticals Inc39.02-4978.03%
BMRNBiomarin Pharmaceutical Inc42.21-5376.89%
KRYSKrystal Biotech Inc45.34-5768.37%
ONCBeiGene Ltd69.54-8793.23%
PHARPharming Group N.V.75.03-9478.92%
TECHBio-Techne Corp101.96-12845.79%
VCELVericel Corp109.92-13841.23%
ALNYAlnylam Pharmaceuticals Inc117.96-14846.78%
GMABGenmab140.29-17637.71%
TLXTelix Pharmaceuticals Ltd162.15-20370.68%
CORTCorcept Therapeutics Inc212.86-26709.26%